Table 2

Human papillomavirus DNA detection among men who have sex with men (n=253)

HPV typeAnalPenilePenile/Anal
N=252N=250N=253
n%n%n%
A. HPV DNA positivity, n (%)
Any type7429.42911.68734.4
High-risk types*
 Any high-risk types5220.6176.86224.5
  1683.20083.2
  1820.810.420.8
  3110.40010.4
  3372.820.883.2
  3531.20031.2
  3962.420.883.2
  4531.20031.2
  5120.810.431.2
  52114.431.2135.1
  5310.40010.4
  5683.210.493.6
  5862.441.683.2
  595220.862.4
  6672.810.472.8
  6710.40010.4
  6872.831.2104
 73 (MM9)10.410.420.8
 Age at recruitment (years)
  20–241621.179.22127.6
  25–291618.633.51719.8
  30–34111958.61424.1
  35–44828.927.1932.1
 45+ (max 50)12000120
Low-risk types†
 Any low-risk types3815.11564718.6
  63212.7124.83815
  1183.210.493.6
  4010.410.420.8
  4272.810.483.2
  540010.410.4
  6220.80020.8
 84 (MM8)0010.410.4
Age at recruitment (years)
  20–241519.767.91823.7
  25–291416.344.71618.6
  30–3435.223.558.6
  35–44517.8310.7725
 45+ (max 50)12000120
 Vaccine-preventable types
  6/11/16/18/31/33/45/52/585722.62086324.9
  6/11/16/184015.9124.84517.8
  6/113313.1124.83915.4
  16/1810410.4104
B. Detection of m ultiple HPV types
Any type
 Range
  017870.622188.416665.6
  13714.7239.24317
  2239.131.22610.3
  3114.431.2145.5
  4+31.20041.6
4-valent vaccine types
 Range
  021284.123895.220882.2
  13011.91043313
  210420.8124.7
9-valent vaccine types
 Range
  019577.42309219075.1
  13915.5176.83915.4
  215631.2218.3
  331.20031.2
  • *High-risk types included type 26, 69, 70 and 82 (MM4), but no one in this sample was detected as such.

  • †Low-risk types included type 55, 61, 64, 71 (CP8061), 72, 81 (CP8304), 83 (MM7), 82V and 89 but no one in this sample was detected as such.

  • HPV, human papillomavirus.